Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage - PubMed (original) (raw)
Affiliations
- PMID: 1404131
Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
R A Greenwald et al. J Rheumatol. 1992 Jun.
Abstract
Tetracyclines are potent inhibitors of 2 major matrix metalloproteinases which have been implicated in connective tissue degradation: collagenase and Type IV collagenase/gelatinase. We directly identified these enzyme activities in extracts of inflamed paw tissue from rats with adjuvant arthritis. Oral tetracycline therapy suppressed metalloproteinase activity in arthritic tissue, but even very high doses failed to exhibit substantial antiinflammatory efficacy (reduced joint swelling and paw diameter). Flurbiprofen, a conventional nonsteroidal antiinflammatory drug, reduced inflammatory indices as expected. The combination of the 2 agents administered orally completely inhibited collagenase activity, significantly inhibited gelatinase activity and produced substantial normalization of radiographic joint damage, far greater than either drug alone. Tetracycline inhibition curves in vitro suggest that the collagenase in this tissue is not of fibroblast origin. Tetracycline derivatives might be useful adjuncts to prevention of tissue damage in chronic inflammatory arthritides.
Similar articles
- Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
Duivenvoorden WC, Hirte HW, Singh G. Duivenvoorden WC, et al. Invasion Metastasis. 1997;17(6):312-22. Invasion Metastasis. 1997. PMID: 9949290 - Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
Zernicke RF, Wohl GR, Greenwald RA, Moak SA, Leng W, Golub LM. Zernicke RF, et al. J Rheumatol. 1997 Jul;24(7):1324-31. J Rheumatol. 1997. PMID: 9228132 - Tenidap and flurbiprofen enhance uptake of matrix metalloproteinase inhibitor 4-dedimethylaminotetracycline in inflamed joints of adjuvant arthritic rats.
Leung MK, Greenwald RA, Ramamurthy NS, Moak SA, Koszulinski R, Dieudonne D, Golub LM. Leung MK, et al. J Rheumatol. 1995 Sep;22(9):1726-31. J Rheumatol. 1995. PMID: 8523353 - Host modulation with tetracyclines and their chemically modified analogues.
Golub LM, Suomalainen K, Sorsa T. Golub LM, et al. Curr Opin Dent. 1992 Mar;2:80-90. Curr Opin Dent. 1992. PMID: 1325849 Review. - The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR. Vernillo AT, et al. Curr Opin Periodontol. 1994:111-8. Curr Opin Periodontol. 1994. PMID: 8032451 Review.
Cited by
- Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.
Hasbum A, Quintanilla J, Jr JAA, Ding MH, Levy A, Chew SA. Hasbum A, et al. Future Med Chem. 2021 Feb;13(4):393-418. doi: 10.4155/fmc-2020-0289. Epub 2021 Jan 5. Future Med Chem. 2021. PMID: 33399488 Free PMC article. Review. - Reconsidering the Use of Minocycline in the Preliminary Treatment Regime of Rheumatoid Arthritis.
Heydari-Kamjani M, Demory Beckler M, Kesselman MM. Heydari-Kamjani M, et al. Cureus. 2019 Aug 8;11(8):e5351. doi: 10.7759/cureus.5351. Cureus. 2019. PMID: 31608186 Free PMC article. Review. - Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?
Horváth Á, Botz B, Kiss T, Csekő K, Kiss I, Felinger A, Szabados T, Kenyeres É, Bencsik P, Mócsai A, Ferdinandy P, Helyes Z. Horváth Á, et al. Front Pharmacol. 2019 Mar 20;10:233. doi: 10.3389/fphar.2019.00233. eCollection 2019. Front Pharmacol. 2019. PMID: 30949048 Free PMC article. - Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity.
Uchimura T, Nakamura DS, Link EM, Noguchi Y, Ōmura S, Sunazuka T, Greenblatt DJ, Zeng L. Uchimura T, et al. Biochem Pharmacol. 2019 Jul;165:79-90. doi: 10.1016/j.bcp.2019.03.014. Epub 2019 Mar 9. Biochem Pharmacol. 2019. PMID: 30862504 Free PMC article. - Liver-Selective MMP-9 Inhibition in the Rat Eliminates Ischemia-Reperfusion Injury and Accelerates Liver Regeneration.
Wang X, Maretti-Mira AC, Wang L, DeLeve LD. Wang X, et al. Hepatology. 2019 Jan;69(1):314-328. doi: 10.1002/hep.30169. Epub 2018 Dec 20. Hepatology. 2019. PMID: 30019419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources